Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
06.06. | Meihua International wechselt zum Nasdaq Capital Market für Compliance | - | Investing.com Deutsch | ||
06.06. | Meihua International Medical Technologies Co., Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
25.04. | Meihua GAAP EPS of $0.40, revenue of $96.91M | 1 | Seeking Alpha | ||
MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
25.04. | Meihua International Medical Technologies Co., Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
25.04. | Meihua International Medical Technologies Co., Ltd. - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
25.04. | Meihua International Medical Technologies Co., Ltd. Full Year Income Retreats | 269 | AFX News | BEIJING (dpa-AFX) - Meihua International Medical Technologies Co., Ltd. (MHUA) released a profit for full year that decreased from the same period last yearThe company's bottom line came in... ► Artikel lesen | |
25.04. | Meihua International Medical Technologies Co., Ltd. Reports 2024 Financial Year Results | 126 | PR Newswire | YANGZHOU, China, April 25, 2025 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer... ► Artikel lesen | |
20.09.24 | Meihua International Medical Technologies Co., Ltd.: Meihua International Medical Technologies Co., Limited Reports Unaudited 2024 First Half Financial Results | 262 | PR Newswire | YANGZHOU, China, Sept. 20, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SERNOVA BIOTHERAPEUTICS | 0,119 | -4,03 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,745 | -2,61 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Positive FDA Feedback, Advances Toward IND for (Z)-Endoxifen Clinical Program in ER+/HER2- Metastatic Breast Cancer | SEATTLE, July 29, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ: ATOS), a clinical-stage biopharmaceutical company developing innovative medicines in oncology, today announced... ► Artikel lesen | |
PING AN HEALTHCARE | 1,340 | +1,32 % | HSI Down 403 pts; HSTI Down 37 pts; MEITUAN Down over 4%; PING AN Down over 4%; MEITU, KINGDEE INT'L, SKB BIO-B, MGM CHINA, PA GOODDOCTOR Hit New Highs; Market Turnover Rises | ||
MOUNTAIN VALLEY MD | 0,011 | -24,00 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
CO-DIAGNOSTICS | 0,242 | +8,04 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
CYTOSORBENTS | 0,780 | +2,23 % | Cytosorbents Corp: CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR | PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions... ► Artikel lesen | |
VERU | 0,430 | -1,06 % | VERU INC. - 8-K, Current Report | ||
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China | Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest... ► Artikel lesen | |
VOLITIONRX | 0,700 | 0,00 % | VolitionRx - Nu.Q advances in lung cancer management | Despite rapid advancements in cancer treatments, effective diagnostics for early screening and disease monitoring continue to be an unmet need. This is felt acutely in lung cancer, which is the leading... ► Artikel lesen | |
EKSO BIONICS | 3,440 | -5,75 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
IMUNON | 7,390 | +11,21 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS15117N6022 Imunon Inc. 24.07.2025 US15117N7012 Imunon Inc. 25.07.2025 Tausch 15:1US92511W1080 Verrica Pharmaceuticals... ► Artikel lesen | |
BEYOND AIR | 2,960 | -4,82 % | Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc. | GARDEN CITY, N.Y., July 22, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
NOVACYT | 0,467 | 0,00 % | Novacyt S.A. - Half-year trading update | ||
AROVELLA THERAPEUTICS | 0,050 | 0,00 % | AROVELLA THERAPEUTICS LIMITED: Investor Presentation |